Pediatric systemic lupus erythematosus: More than a positive antinuclear antibody

Pediatrics in Review

Volumn 33, Issue 2, 2012, Pages 62-74

  Weiss, Jennifer E ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BELIMUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROXYCHLOROQUINE; ISONIAZID; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; QUINIDINE; RITUXIMAB; TACROLIMUS; TUMOR NECROSIS FACTOR INHIBITOR;

ABDOMINAL DISCOMFORT; ALOPECIA; ANOREXIA; ARTHRALGIA; ARTHRITIS; ARTHROPATHY; BONE MARROW SUPPRESSION; BURNING SENSATION; CEREBROVASCULAR DISEASE; DISCOID LUPUS ERYTHEMATOSUS; DRUG MEGADOSE; ENDOCARDITIS; EPSTEIN BARR VIRUS; ETHNICITY; EYE TOXICITY; FATIGUE; FEVER; GLAUCOMA; GLOMERULONEPHRITIS; HEADACHE; HEMATURIA; HEPATOSPLENOMEGALY; HUMAN; HYPERTENSION; HYPOGONADISM; HYPOTHYROIDISM; IMMUNOPATHOLOGY; KIDNEY DISEASE; LUNG HEMORRHAGE; LUPUS LIKE SYNDROME; LYMPHADENOPATHY; MENSTRUAL IRREGULARITY; MENTAL DISEASE; MOOD DISORDER; MOUTH ULCER; MYALGIA; MYELITIS; MYOSITIS; NEPHRITIS; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; PARVOVIRUS; PERICARDIAL EFFUSION; PERICARDITIS; PERSONALITY DISORDER; PHOTOSENSITIVITY; PLEURISY; PNEUMONIA; PROTEINURIA; PSYCHOSIS; PURPURA; RASH; RAYNAUD PHENOMENON; REVIEW; SHORT STATURE; SIDE EFFECT; SLEEP DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS; VASCULITIC RASH; VASOSPASM; WEIGHT GAIN; WEIGHT REDUCTION;

ANTIBODIES, ANTINUCLEAR; CHILD; GLUCOCORTICOIDS; HUMANS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUSCULOSKELETAL DISEASES;

EID: 84860796220     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.33-2-62     Document Type: Review

References (10)

1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725
2. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum. 1973;3(1):1-54
3. Benseler SM, Silverman ED. Systemic lupus erythematosus. Pediatr Clin North Am. 2005;52(2):443-467, vi (Pubitemid 40463662)
4. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E, Silverman ED. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. J Pediatr. 2008;152(4):550-556 (Pubitemid 351381032)
5. Weening JJ, D'Agati VD, Schwartz MM, et al. on behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241-250 (Pubitemid 38140764)
6. Bertsias GK, Salmon JE, Boumpas DT. Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis. 2010;69(9):1603-1611
7. Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus - a meta-analysis. Lupus. 1997;6(5):467-473 (Pubitemid 27395386)
8. Schanberg LE, Sandborg C, Barnhart HX, et al Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009;60(5):1496-1507
9. Malleson PN, Sailer M, Mackinnon MJ. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child. 1997;77(4):299-304 (Pubitemid 27449250)
10. Kamanamool N, McEvoy M, Attia J, Ingsathit A, Ngamjanyaporn P, Thakkinstian A. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis. Medicine (Baltimore). 2010;89(4):227-235